Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Technical Analysis

387 Followers

Summary of all the Indicators

Summary
Strong Buy
16Bullish
6Neutral
0Bearish
Oscillators
Buy
4Bullish
6Neutral
0Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
Ultragenyx Pharmaceutical’s (RARE) Moving Averages Convergence Divergence (MACD) indicator is 1.69, suggesting Ultragenyx Pharmaceutical is a Buy.
Ultragenyx Pharmaceutical’s (RARE) 20-Day exponential moving average is 48.48, while Ultragenyx Pharmaceutical’s (RARE) share price is $50.85, making it a Buy.
Ultragenyx Pharmaceutical’s (RARE) 50-Day exponential moving average is 45.77, while Ultragenyx Pharmaceutical’s (RARE) share price is $50.85, making it a Buy.

Ultragenyx Pharmaceutical (RARE) Pivot Points

Jun 03, 2023, 04:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
46.57
47.34
48.47
49.24
50.37
51.14
52.27
Fibonacci
47.34
48.06
48.51
49.24
49.96
50.41
51.14

Ultragenyx Pharmaceutical (RARE) Moving Averages

Jun 03, 2023, 04:41 PM
Period
Simple
Exponential
MA5
49.61Buy
49.95Buy
MA10
50.00Buy
49.63Buy
MA20
48.99Buy
48.48Buy
MA50
43.86Buy
45.77Buy
MA100
43.59Buy
44.50Buy
MA200
42.74Buy
45.23Buy
Ultragenyx Pharmaceutical’s (RARE) 10-Day exponential moving average is 49.63, while Ultragenyx Pharmaceutical’s (RARE) share price is $50.85, making it a Buy.
Ultragenyx Pharmaceutical’s (RARE) 100-Day exponential moving average is 44.50, while Ultragenyx Pharmaceutical’s (RARE) share price is $50.85, making it a Buy.
Ultragenyx Pharmaceutical’s (RARE) stock price is $50.85 and Ultragenyx Pharmaceutical’s (RARE) 50-day simple moving average is 43.86, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $50.85 and Ultragenyx Pharmaceutical’s (RARE) 100-day simple moving average is 43.59, creating a Buy signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $50.85 and Ultragenyx Pharmaceutical’s (RARE) 200-day simple moving average is 42.74, creating a Buy signal.

Ultragenyx Pharmaceutical (RARE) Technical Indicators

Jun 03, 2023, 04:41 PM
Name
Value
Action
RSI (14)
62.15
Neutral
STOCH (9,6)
48.96
Neutral
STOCHRSI (14)
62.48
Neutral
MACD (12,26)
1.69
Buy
ADX (14)
48.82
Neutral
Williams %R
-22.07
Buy
CCI (14)
95.74
Neutral
ATR (14)
2.06
-
Ultimate Oscillator
50.04
Neutral
ROC
7.96
Buy
Ultragenyx Pharmaceutical’s (RARE) Relative Strength Index (RSI) is 62.15, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Trend Strength Indicator (ADX) is 48.82, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Commodity Channel Index (CCI) is 95.74, creating a Neutral signal.
Ultragenyx Pharmaceutical’s (RARE) Price Rate of Change (ROC) is 7.96, creating a Buy signal.

FAQ

Is RARE a Buy, Hold, or Sell?
Based on RARE’s technical indicators, RARE is a Strong Buy.
    What is RARE’s RSI (14)?
    RARE’s RSI (14) is 62.15, which suggests RARE is a Neutral.
      What is RARE’s MACD?
      RARE’s MACD is 1.69, which suggests RARE is a Buy.
        What is RARE’s 5-day moving average?
        RARE’s 5-day moving average is 49.61, which suggests RARE is a Buy.
          What is RARE’s 20-day moving average?
          RARE 20-day moving average is 48.99, which suggests RARE is a Buy.
            What is RARE’s 50-day moving average?
            RARE’s 50-day moving average is 43.86, which suggests RARE is a Buy.
              What is RARE’s 200-day moving average?
              RARE’s 200-day moving average is 42.74, which suggests RARE is a Buy.
                What is RARE’s Williams % R (14)?
                RARE’s Williams % R (14) is -22.07, which suggests RARE is a Buy.
                  What is RARE’s CCI (14)?
                  RARE’s CCI (14) is 95.74, which suggests RARE is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis